Novartis Lamisil, Janssen Sporanox Liver Toxicity Warning Added To Labeling
Novartis Lamisil patients should be assessed for pre-existing liver disease before receiving the antifungal tablets, revised labeling recommends.
Novartis Lamisil patients should be assessed for pre-existing liver disease before receiving the antifungal tablets, revised labeling recommends.